TL;DR
This study investigates the impact of China's Diagnosis-Related Groups (DRG) payment reform on healthcare costs and length of stay for patients with lumbar disc herniation (LDH) treated with Traditional Chinese Medicine (TCM). While the reform successfully reduced overall hospitalization costs, its effects on specific cost components and patient stay duration were more nuanced, highlighting opportunities for further optimization.
What Problem Does This Paper Address?
Low back pain, particularly lumbar disc herniation (LDH), is a major global health issue imposing a significant economic burden. Traditional Chinese Medicine (TCM) offers effective, often conservative, treatment options for LDH. To better integrate TCM into the healthcare system and control rising costs, China has been implementing a Diagnosis-Related Groups (DRG) payment reform. This reform aims to standardize hospital payments based on patient diagnoses and procedures. However, the specific impact of this reform on TCM hospitals and treatments for conditions like LDH, where TCM has distinct advantages, remains underexplored. This paper aims to unpack these cost implications, providing evidence for refining DRG policies in the context of TCM.
Methods
The researchers employed a quasi-experimental design using an interrupted time-series analysis (ITSA) model. This method is well-suited for evaluating the impact of policy changes (like the DRG reform) on longitudinal data. They analyzed data from hospitalized LDH patients at Qingyang City Hospital of Chinese Medicine from January 2017 to June 2022, with the DRG reform implemented in October 2019.
Key aspects of their methodology include:
- Univariate Analysis: To compare patient demographics and characteristics before and after the DRG reform.
- Interrupted Time-Series Analysis (ITSA): To assess changes in trends of healthcare costs (hospitalization cost, medical services cost, diagnosis cost, TCM treatment cost, Chinese medicine cost, Western medicine cost) and length of stay before and after the intervention (DRG reform). This model accounts for pre-existing trends and sudden level changes.
- Multiple Linear Regression and Spearman Correlation: To identify factors influencing healthcare costs and length of stay and to examine relationships between these variables.
- Autocorrelation Tests (Cumby-Huizinga): To check for and address autocorrelation in the time-series data, ensuring the robustness of the ITSA model.
Datasets
The study utilized retrospective data from hospitalized patients diagnosed with Lumbar Disc Herniation (LDH) at Qingyang City Hospital of Chinese Medicine, Gansu Province, China. The dataset covered the period from January 2017 to June 2022, encompassing 2,857 valid cases.
- Inclusion Criteria: Patients with specific TCM and ICD-10 codes for LDH, with a length of stay between 1 and 90 days, and non-zero hospitalization costs.
- Exclusion Criteria: Patients with very short or long stays, zero costs, or logically inconsistent visit information.
No new benchmarks were introduced; the study focused on analyzing existing hospital data under a new policy framework.
Key Insights and Ideas
- DRG Reform's Dual Impact: The reform successfully curbed the overall upward trend in hospitalization costs, but its impact was not uniform across all cost categories.
- TCM's Role in Cost Containment: While Western medicine costs decreased significantly post-reform, Chinese medicine costs also saw a reduction, suggesting that the reform incentivizes more cost-effective TCM utilization.
- Complexity Matters: The reform seemed to attract more complex cases (higher incidence of complications, comorbidities, and surgeries), which, while potentially increasing reimbursement, also highlights the need for nuanced DRG classifications.
- Length of Stay Paradox: Despite cost reductions, the length of stay for LDH patients did not decrease, contrary to findings in other DRG studies. This suggests that TCM's therapeutic approach, with its focus on holistic treatment and slower onset of effects, may require longer durations for optimal outcomes, posing a challenge for traditional DRG cost-containment goals.
- Policy Implications for TCM: The study underscores the need to tailor DRG policies to the unique characteristics of TCM, potentially by developing specific reimbursement standards that account for TCM's strengths in chronic disease management and its distinct treatment modalities.
Key Results
- Overall Hospitalization Cost: Decreased by an average of CNY 36.78 per month post-reform.
- Chinese Medicine Cost: Decreased by an average of CNY 8.87 per month post-reform.
- Western Medicine Cost: Decreased by an average of CNY 31.68 per month post-reform.
- Medical Services Cost: Showed a significant increase during the reform period (CNY 361.98) but did not show a significant trend post-reform.
- Diagnosis Cost: The upward trend pre-reform was curtailed, and it significantly decreased during the reform (CNY 307.11), with no significant post-reform trend.
- TCM Treatment Cost: Showed a significant increase post-reform (average monthly increase of CNY 50.08).
- Length of Stay: Did not show a statistically significant change pre- or post-reform.
- Patient Demographics: Post-reform, there was an increase in female patients, older patients, and those admitted through other pathways or with more complex conditions.
Limitations and Future Work
- Limited Scope: The study was conducted at a single hospital, which may limit the generalizability of findings to other TCM hospitals or healthcare settings.
- Length of Stay: The lack of reduction in length of stay, despite cost savings, is a key limitation. The authors suggest that future DRG reforms should focus on enhancing TCM treatment outcomes and potentially integrating TCM's unique advantages to shorten hospitalization times where appropriate.
- TCM Specificity: The authors emphasize the need to further refine DRG payment systems to better accommodate the distinctive characteristics of TCM, such as its holistic approach and cumulative treatment effects, to achieve more comprehensive cost reduction and quality improvement.
- Future Research: The authors suggest exploring unique reimbursement frameworks for TCM and optimizing treatment methods to further reduce patient costs and length of stay.
Summary updated